![Deborah A. Quinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Deborah A. Quinn worked as a Medical Director for Pulmonary Arterial Hypertension at Novartis Pharmaceuticals AG from 2006 to 2015.
She then worked as the Chief Medical Officer at Bellerophon Therapeutics, Inc. from 2015 to 2018.
Prior to that, she was an Assistant Professor at Harvard Medical School from 2006 to 2011.
Quinn holds a doctorate degree from the University of Massachusetts Medical School.
Anciens postes connus de Deborah A. Quinn
| Sociétés | Poste | Fin |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 26/10/2018 |
Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01/01/2015 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2011 |
Formation de Deborah A. Quinn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMass Chan Medical School
 UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals AG |
